IUPAC/Chemical Name
Hexanamide, 2,6-diamino-, (2S)-
InChi Key
HKXLAGBDJVHRQG-YFKPBYRVSA-N
InChi Code
InChI=1S/C6H15N3O/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H2,9,10)/t5-/m0/s1
SMILES Code
O=C(N)[C@@H](N)CCCCN
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
145.21
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK501918/ PubMed PMID: 30000978.
2: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500975/ PubMed PMID: 30000034.
3: Chopra A. [(99m)Tc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-l ysyl-L-valyl), (1‡1´)-sulfide with 3-[(mercaptoacetyl)amino]-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide. 2008 Mar 27 [updated 2008 May 27]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK23269/ PubMed PMID: 20641471.
4: Zahmatkesh S, Vakili MR. Synthesis and Characterization of New Optically Active Poly (ethyl L-lysinamide)s and Poly (ethyl L-lysinimide)s. J Amino Acids. 2010;2010:910906. doi: 10.4061/2010/910906. Epub 2010 Jul 13. PubMed PMID: 22331998; PubMed Central PMCID: PMC3276056.
5: Furuta S, Shimada O, Doi N, Ukai K, Nakagawa T, Watanabe J, Imaizumi M. General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung. 2004;54(12):868-80. PubMed PMID: 15646371.
6: Doi N, Hirotani C, Ukai K, Shimada O, Okuno T, Kurasaki S, Kiyofuji T, Ikegami R, Futamata M, Nakagawa T, Ase K, Chihara K. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung. 2004;54(12):857-67. PubMed PMID: 15646370.
7: Levengood J, Ataide SF, Roy H, Ibba M. Divergence in noncognate amino acid recognition between class I and class II lysyl-tRNA synthetases. J Biol Chem. 2004 Apr 23;279(17):17707-14. Epub 2004 Jan 27. PubMed PMID: 14747465.
8: Choi JS, Lee EJ, Jang HS, Park JS. New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. Bioconjug Chem. 2001 Jan-Feb;12(1):108-13. PubMed PMID: 11170373.
9: Kliment'eva TA, Galaev IuV, Brel' AK. [Activity and properties of L-lysine amidase in Salmonella strains]. Ukr Biokhim Zh (1978). 1990 Jul-Aug;62(4):84-7. Russian. PubMed PMID: 2238158.
10: Wang SS, Carpenter FH. Kinetic studies at high pH of the trypsin-catalyzed hydrolysis of N-alpha-benzoyl derivatives of L-arginamide, L-lysinamide, and S-2-aminoethyl-L-cysteinamide and related compounds. J Biol Chem. 1968 Jul 10;243(13):3702-10. PubMed PMID: 5658546.
